Aino Health AB (publ) (STO:AINO)
0.1370
+0.0130 (10.48%)
Jun 5, 2026, 5:30 PM CET
Aino Health AB Revenue
Aino Health AB had revenue of 5.53M SEK in the quarter ending March 31, 2026, a decrease of -25.03%. This brings the company's revenue in the last twelve months to 24.27M, down -4.18% year-over-year. In the year 2025, Aino Health AB had annual revenue of 26.11M with 9.07% growth.
Revenue (ttm)
24.27M
Revenue Growth
-4.18%
P/S Ratio
1.16
Revenue / Employee
1.35M
Employees
18
Market Cap
28.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.11M | 2.17M | 9.07% |
| Dec 31, 2024 | 23.94M | 21.00K | 0.09% |
| Dec 31, 2023 | 23.92M | 4.01M | 20.15% |
| Dec 31, 2022 | 19.91M | -3.14M | -13.61% |
| Dec 31, 2021 | 23.04M | -2.39M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.52B |
| Camurus AB | 2.24B |
| Perpetua Medical AB | 16.92M |
| Enorama Pharma AB | 3.86M |
| Biosergen AB | 2.09M |
| Prostatype Genomics AB | 594.00K |
Aino Health AB News
- 22 days ago - Aino Health AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Aino Health AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Aino Health AB Annual report: Q4 2025 - Filings
- 7 months ago - Aino Health AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Aino Health AB Quarterly report: Q2 2025 - Filings